By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • The Wire
  • Health Topics
  • Podcast & Media
  • GMJ Articles
  • Perspectives
  • Policy & Systems
  • Dictionary
  • Practice
  • Research Digest
  • Read the Journal →
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Follow US
GMJ News > Perspectives > Explainers > The Georgian Supplement Market: What the Law Requires — and What Compliance Reviews Find
ExplainersHealth PolicyQuality & Safety

The Georgian Supplement Market: What the Law Requires — and What Compliance Reviews Find

GMJ
Last updated: 13/09/2026 21:19
By
GMJ Perspectives Desk
Share
8 Min Read
Food supplements on the Georgian retail market
SHARE
🎧 Listen to this article6:36 min · 980 words · GMJ Audio

Updated 13/09/2026

Contents
  • What the law requires
  • What compliance reviews find
  • Why enforcement is limited
  • What consumers can do now
  • The approximation timeline: why EU rules govern a non-EU market
  • Anatomy of a compliant label: the checklist
  • How a market review is actually conducted
  • What good enforcement looks like: models worth importing
  • The clinical bottom line
  • Primary sources
5 min read|980 words

Georgia’s food-supplement rules are, on paper, closely modelled on the European framework. The gap the Public Health Institute of Georgia (PHIG) documents in its ongoing market reviews is not legislative — it is the distance between what the law requires and what products on shelves can actually demonstrate.

What the law requires

The EU’s Directive 2002/46/EC — the reference framework for Georgian approximation under the Association Agreement — defines supplements as concentrated nutrient sources in dose form, restricts vitamins and minerals to positive-listed substances (Annexes I–II), and mandates labelling that includes recommended daily dose, a warning not to exceed it, a statement that supplements do not replace a varied diet, and a keep-away-from-children notice. Georgian food legislation adds the national layer: business-operator registration with the National Food Agency, product notification before marketing, Georgian-language labelling, and traceability sufficient for recall. Together this creates a three-part legal minimum: legal ingredients, compliant label, registered and traceable operator.

What compliance reviews find

PHIG’s investigative documentation of products sold in Georgia — pharmacy chains, retail, and online/imported channels — repeatedly surfaces the same failure categories. No certificate of analysis: distributors unable to produce any batch-level CoA, meaning identity and potency of the actual lot are undemonstrated. No heavy-metal or contaminant testing: no lead/arsenic/cadmium/mercury data for products whose ingredient classes (botanical extracts, marine oils, clays) are precisely the higher-risk categories. Labelling failures: missing Georgian-language labels on imports, absent mandatory warnings, undeclared dosage-exceedance cautions, and claims language crossing into prohibited disease-treatment territory. Registration gaps: parcel-import and social-media sales operating entirely outside NFA notification — beyond the recall system’s reach. Individual product cases from these reviews are handled through formal regulatory correspondence rather than publication; the categories above are the market-level pattern.

Submit Your Paper
GMJ_Submit_Banner
🎙️ Related Podcast Episodes
🎧 #37 | GMJ Podcast | NAD⁺ Injections and “NAD Boosters” — Public Health Risks and Regulatory Implications · 20m
🎧 #53 | GMJ Podcast | Palliative Care in Georgia — Health System Gaps, Access Barriers, and Policy Implications · 16m
🎧 #52 | GMJ Podcast | Health and Migration Knowledge Hub — A Global Resource for Evidence-Based Practice · 17m
🎧 #46 | GMJ Podcast | Angioplasty of Saphenous Vein Grafts — Risks, Outcomes, and Clinical Strategies · 21m
🎧 #36 | GMJ Podcast | Artificial Intelligence and Doctor–Patient Communication — Evidence from Georgian Clinics · 18m

Why enforcement is limited

Three structural reasons. Supplement oversight competes for the same inspection capacity as core food safety; post-market laboratory surveillance (buying and testing shelf products) is resource-intensive and therefore rare; and cross-border e-commerce places a growing share of the market outside territorial jurisdiction altogether. None of this is unique to Georgia — but a smaller market feels each constraint more sharply.

What consumers can do now

Until enforcement catches up with the framework, verification burden sits with the buyer, and three questions do most of the work: Is the product NFA-notified (a registered importer will say so)? Can the seller produce a batch-specific CoA from an accredited laboratory, including heavy metals? Does the label carry the mandatory statements in Georgian? A “no” to any of these is a stronger signal than any marketing claim.

The approximation timeline: why EU rules govern a non-EU market

Georgia’s supplement framework is not voluntarily EU-flavoured — it is treaty-bound. The 2014 EU–Georgia Association Agreement, with its Deep and Comprehensive Free Trade Area, obliges Georgia to approximate defined chapters of the EU food-safety acquis on a scheduled basis, Directive 2002/46/EC among the reference acts, with the National Food Agency as the competent authority whose functions mirror member-state models. The strategic logic is export access: Georgian food products reach EU markets only through demonstrable regulatory equivalence. For consumers the practical consequence is convenient — the compliance questions to ask in Tbilisi are the same ones asked in Vilnius or Lisbon, and the EU’s public documents (positive lists, labelling rules, RASFF alerts) function as a free reference library for the Georgian market.

Anatomy of a compliant label: the checklist

A supplement label meeting the 2002/46/EC-derived requirements carries, at minimum: the sales name including the word designating it a food supplement; the nutrient/substance categories characterising it; the recommended daily portion with a warning not to exceed it; nutrient amounts declared per that daily portion, with vitamins and minerals also as % NRV; the statement that supplements are not a substitute for a varied diet; the keep-out-of-reach-of-children notice; and — the national layer — all of it in Georgian, with a named responsible operator reachable at a Georgian address. Each element is checkable in thirty seconds at a shelf, which is exactly what makes labelling audits the highest-yield, lowest-cost compliance instrument a reviewer has.

How a market review is actually conducted

PHIG’s methodology follows standard market-surveillance practice, kept at pattern level here by design. Sampling frame: products drawn across the three retail channels — pharmacy chains, physical retail, and online/social-media import sellers — because compliance stratifies sharply by channel. Document request: each seller/distributor asked for the two artefacts the law presumes to exist: proof of NFA notification, and a batch-specific certificate of analysis including identity, potency and heavy metals. Label audit: the checklist above, item by item. Classification: findings recorded as failure categories rather than brand verdicts, with individual cases routed into formal regulatory correspondence — the channel where naming names belongs, with due process attached. The published output is therefore a market diagnosis, not a blacklist: deliberately.

What good enforcement looks like: models worth importing

The gap being administrative capacity rather than legal text, the fixes are known machinery. Risk-based post-market testing — concentrating laboratory budgets on the categories where alerts cluster (botanical slimming and enhancement products, imported protein powders). Alert-network integration — full exploitation of RASFF and WHO INFOSAN feeds so that a batch flagged in Warsaw is checked in Tbilisi within days. Channel enforcement — treating social-media sellers as food business operators with registration duties, as EU market-surveillance practice increasingly does. And publication of surveillance results in aggregate, which disciplines the market without litigating individual reputations. Each of these is incremental, budgetable, and proven elsewhere — the encouraging part of an otherwise sobering audit.

The clinical bottom line

Georgia’s supplement law is EU-shaped; the documented market is not yet. The recurring failures are demonstrability failures — no CoA, no contaminant data, no compliant label — which is exactly why independent batch testing and transparent registration are the trust signals worth demanding.

Primary sources

  • Directive 2002/46/EC on food supplements (consolidated)
  • National Food Agency of Georgia — registration and control functions
  • WHO: food-safety surveillance and INFOSAN framework
  • PHIG market-review documentation, 2025–2026 (institutional file; regulatory correspondence basis)

🗺️ Find certified Georgian healthcare providers: sheniekimi.ge — Georgia Health Map · 998 clinics · 6,600+ doctors · 2,296 pharmacies

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Clare Bannon Elected Chair of BMA General Practitioners Committee EnglandOct 6, 2026
Medicare Proposes Fresh Cuts to Hospital 340B Drug Discount ProgramOct 6, 2026
Transgender Sports Bans May Increase Body Scrutiny Risk for All Girls, Experts WarnOct 6, 2026
A 10-Second Daily Finger Exercise May Support Cognitive Function, New Research SuggestsOct 6, 2026
Explore more on this topic:🧭 Supplements & Nutraceuticals hub🧭 African Trypanosomiasis (Sleeping Sickness) hub🧭 Essential Tremor hub
🔥 Most read this week
1Animal Protein’s Muscle-Building Edge Disappears When Measured Over Days, Not Hours
2Animal Protein Produces 47% Larger Muscle Protein Synthesis Spike Than Plant Sources, New Research Shows
3High-Intensity Interval Training Alone Preserves Muscle While Reducing Fat in Older Adults
4Short sleep duration linked to weight gain and reduced activity in six-week study
Related reference
  • SAMe · Ingredient

Find certified Georgian healthcare providers at sheniekimi.ge/jandacvis-ruka/

PG
Editorial oversight
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
📬 GMJ Health Digest
Evidence-based medical news, once a week. Free, no spam, unsubscribe anytime.
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Bluesky Copy Link Print
GMJ
ByGMJ Perspectives Desk
Follow:
GMJ Perspectives Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
When Recalibration Reproduces Inequity: The Pulse Oximetry Paradox and Why Device Standards Must Account for Melanin

Pulse oximeter recalibration that shifted from overestimation to underestimation in darker-skinned patients…

Clare Bannon Elected Chair of BMA General Practitioners Committee England

Dr. Clare Bannon, a general practitioner from Barnsley, has been elected chair…

Medicare Proposes Fresh Cuts to Hospital 340B Drug Discount Program

Medicare has announced a new proposal to reduce payment rates for drugs…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Nuts, seeds and oils — the main dietary sources of vitamin E
ExplainersNew Studies

Vitamin E: Why 9 in 10 Fall Short — and Why the Natural Form Is Retained Better

By
GMJ Perspectives Desk
20/08/2026
MHRA regulatory performance dashboard showing drug approval pathways and timelinesIllustrative image · Photo by RDNE Stock project on Pexels (Pexels License)
Health PolicyPolicy & SystemsQuality & Safety

UK’s MHRA Publishes Performance Data: Drug Approvals, Review Times, and Regulatory Efficiency Metrics

By
GMJ Policy Desk
09/08/2026
Illustration of bone cells (osteoblasts) releasing osteocalcin hormone into bloodstream, connecting to pancreas and skeletal muscle in a metabolic feedback loopIllustrative image · Photo by Pavel Danilyuk on Pexels (Pexels License)
ExplainersNew StudiesPerspectivesResearch Digest

Bones Are Metabolic Organs: How Mechanical Loading Regulates Blood Sugar

By
GMJ Perspectives Desk
23/07/2026
Global HealthGMJ ArticlesHealth PolicyMigration & HealthVol. 1 Issue 2 (2026)

The People Nobody Covers: Migrants in Transit and the Test of Universal Health Coverage

By
GMJ Policy Desk
28/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Accreditation Canada in Georgia
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?